Glioblastoma multiforme (GBM) is a highly lethal and aggressive tumor of the brain that
carries a poor prognosis. Temozolomide (TMZ) has been widely used as a first-line …

Glioblastoma is the most common malignant brain tumor. Efficient delivery of drugs targeting
glioblastomas remains a challenge. Ephrin type-A receptor 3 (EPHA3) tyrosine kinase …

The treatment of central nervous system (CNS) malignancies, including brain cancers, is
limited by a number of obstructions, including the blood-brain barrier (BBB), the …

Based on the overexpression of specific receptors on tumor cells, active targeting
nanomedicines have been developed with the ability to efficiently deliver imaging agents in …

Purpose Glioblastoma multiforme (GBM) is the most common malignant brain tumor
originating in the central nervous system in adults. Based on nanotechnology such as …

Background: Malignant brain tumor is a highly challenging disease for diagnosis, treatment,
and management. Cytotoxicity, distribution and the ability to cross blood brain barrier are …

A successful drug delivery to a specific site relies on two essential factors including; efficient
entrapment of the drug within the carrier and successful delivery of drug-loaded nanocarrier …

As the most common malignant brain tumors, glioblastoma multiforme (GBM) was
characterized by angiogenesis and tumor cells proliferation. Dual targeting to …

In this study, NiO nanosheets have been manufactured using a co-precipitation approach
that involved the usage of nickel nitrate (Ni (NO 3) 2. 6H 2 O) as the raw material and …

Context: Glioblastoma is a malignant brain tumor originating in the central nervous system.
Successfully therapy of this disease required the efficient delivery of therapeutic agents to …